About AmbioPharm


AmbioPharm was founded in 2006 and is one of the largest peptide commercial manufacturers in the world.  With facilities in North Augusta, South Carolina, and Shanghai, China, we employ more than 500 chemists and industry professionals.

A New Business Model

AmbioPharm has developed a unique business model designed to handle all types of peptide manufacturing.  We can handle any scale project from large to small.

In addition to our years of experience and a stellar reputation in the industry, here are three reasons you should consider AmbioPharm:

  1. Highest Quality at Lower Costs
    Our unique business model gives us the ability to produce high quality products of any scale at a lower price than most competitors.
  2. Fast Process
    AmbioPharm can deliver custom peptides reviewed and released by our in-house Quality Control Unit in as little as 3-4 weeks.
  3. Scalability
    AmbioPharm is capable of efficiently manufacturing peptide of any batch size from milligrams all the way to multi-kilograms and even metric tons.

Contract GMP Peptide Manufacturing

Serving pharmaceutical, research, and biotech companies, we can perform solid-phase, solution-phase, and/or hybrid peptide chemistry as well as:

  • Organic Conjugations to Proteins
  • Toxoids
  • Antifungals
  • KLH (Keyhole Limpet Hemocyanin)
  • PEG (Polyethylene Glycol)

Upon request, we can also provide research-grade peptides for pre-clinical in vitro, medicinal efficacy, and toxicology programs.  This service provides you with milligrams to multi-grams of research-grade peptides that have been fully qualified and released by our in-house Quality Control team.

Generic Peptide Drugs

In addition to contract peptide manufacturing, we partner with generic drug companies to provide generic peptide APIs for established commercial markets throughout the world.

Manufacturing Facilities

Our manufacturing facilities have eight process development suites operating in parallel with multiple reactor vessels up to 1,000L (100kg crude peptide/batch) for solid-phase synthesis and solution reactors up to 5,000L (200kg crude peptide/batch). We maintain scalable HPLC purification systems up to 60cm (28kg pure peptide/batch) and multiple lyophilization systems up to 400L (30kg pure peptide/batch).

Our two cGMP peptide manufacturing facilities in the US and China can handle any manufacturing scale required. We currently operate multiple manufacturing lines capable of sustaining campaigns from grams to 400 kg/year.

For commercial products, we design dedicated facilities at even larger scales to meet current and future needs of our clients. In addition, on-going expansion at our facilities will significantly add to our capacity at all of our sites

Management Team

The management team as AmbioPharm, Inc. has more than a hundred fifty years of cumulative experience in manufacturing Pharmaceutical-grade peptide projects.

SETTING A NEW STANDARD

For Peptide API Manufacturing and Services

Have a Peptide project?